跳至主要内容
临床试验/NCT03525301
NCT03525301Unknown不适用

SHort Course Accelerated RadiatiON Therapy (SHARON) in Palliative Treatment of Brain Metastases: an Interventional, Randomised, Multicentric Study

IRCCS Azienda Ospedaliero-Universitaria di Bologna2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2017年11月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
108
试验地点
2
主要终点
Efficacy of palliation using the short course scheme compared with the standard scheme

研究概览

简要总结

Aim of the study is to assess efficacy of a short course radiation treatment in patients with symptomatic brain metastases from solid tumors

详细描述

Standard treatment for brain metastases (3000 cGy in 10 daily fractions of 300 cGy each) is compared with experimental treatment (1800 cGy in 4 fractions of 450 cGy twice a day) to demonstrate non-inferiority of this scheme

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic brain metastases from solid tumors
  • age > 18 years
  • ECOG performance status 0-3
  • no changes in supportive care in the week before radiotherapy

排除标准

  • pregnancy
  • previous irradiation of the same region

研究组 & 干预措施

standard treatment

Active Comparator

patients in this group are treated with 3000 cGy in 10 daily fractions

干预措施: standard treatment (Radiation)

short course treatment

Experimental

patients in this group are treated with 1800 cGy in 4 fractions administered twice a day (at least 6-8 hours interval)

干预措施: short course treatment (Radiation)

结局指标

主要结局

Efficacy of palliation using the short course scheme compared with the standard scheme

时间窗: 3 months

Reduction of initial symptoms after radiotherapy, assessed with Likert scale (weakness, motor disorders, cognitive impairment, personality changes, loss of balance, seizures, changes in speech, vision, hearing, memory problems, nausea or vomiting are evaluated as none-mild-moderate-severe)

次要结局

  • Acute toxicity in the two treatment groups(3 months)
  • Late toxicity in the two treatment groups(12 months)
  • Quality of Life (QoL) assessment in the two groups(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

研究点 (2)

Loading locations...

相似试验